Published in Cancer Weekly, February 24th, 1997
The company also announced that on January 28, 1997, it started initial clinical trials of T-4GEN, PharmaPrint's patented pharmaceutical version of mistletoe intended to treat HIV and cancer patients. The trials are performed on healthy volunteers in the United Kingdom.
The three pharmaceutical versions of natural medicines the company is currently processing are saw palmetto, to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.